Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 7/20 | 0.44 |
| ▸ | OXTR | P30559 | 4/20 | 0.44 |
| ▸ | AVPR2 | P30518 | 3/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.42 |
| ▸ | NAMPT | P43490 | 2/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
| ▸ | DRD2 | P14416 | 2/20 | 0.37 |
| ▸ | DRD4 | P21917 | 2/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2581912 | 0.90 | AVPR1A (0.43) | AVPR1AOXTRAVPR2KCNH2NAMPT | |
| SCHEMBL2542001 | 0.89 | OXTR (0.58) | AVPR1AOXTRAVPR2KCNH2 | |
| SCHEMBL2542000 | 0.89 | OXTR (0.58) | AVPR1AOXTRAVPR2KCNH2 | |
| SCHEMBL2575253 | 0.89 | AVPR1A (0.42) | AVPR1AOXTRAVPR2KCNH2NAMPT | |
| SCHEMBL2579313 | 0.89 | AVPR1A (0.42) | AVPR1AOXTRAVPR2KCNH2NAMPT | |
| SCHEMBL2582650 | 0.88 | AVPR1A (0.51) | AVPR1AOXTRAVPR2KCNH2 | |
| SCHEMBL2581562 | 0.86 | AVPR1A (0.43) | AVPR1AOXTRAVPR2KCNH2NAMPT | |
| SCHEMBL2578240 | 0.84 | AVPR1A (0.50) | AVPR1AOXTRAVPR2KCNH2NAMPT | |
| SCHEMBL2574631 | 0.83 | AVPR1A (0.45) | AVPR1AOXTRAVPR2KCNH2NAMPT | |
| SCHEMBL2544943 | 0.81 | OXTR (0.59) | AVPR1AOXTRAVPR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2560975-A1 | HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2013-02-27 | — | — | EP | claimed |
| WO-2011131596-A1 | HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-10-27 | — | — | WO | claimed |
| EP-2560975-A1 | HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2013-02-27 | — | — | EP | disclosed |
| WO-2011131596-A1 | HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-10-27 | — | — | WO | disclosed |